Prof. Marcin Kołaczkowski, the Leading Scientist at Adamed, awarded for work on the therapy of psychiatric diseases

About Adamed
About Adamed
Adamed in Poland
Adamed across the globe
Management Team of Adamed Pharma S.A.
Mission and values
Ethics and Compliance
Adamed for the Family
News
Adamed is a pharmaceutical and biotechnology company with almost 40 years of experience, founded on the basis of Polish scientific advances and a patent portfolio.
Products
Produkty
Prescription drugs
OTC drugs
Dietary supplements
Dermocosmetics
Medical devices
We provide patients with the highest quality medicinal products that are a response to chronic civilization diseases in several therapeutic areas.
Development and innovation
Development and innovation
Research
Development of proprietary medicines
Development of value-added medicines
Business development Startups Requests for proposals and tenders
Innovation is at the core of Adamed’s evolution. It allows us to pursue our mission by responding to the key challenges of modern medicine.
ESG
CSR
Adamed Foundation
Social programmes
Code of Ethics
Responsibility is one of our key values. It is at the core of everything we do and has earned us the trust of patients and the medical community.
Career
Career
Benefits
Development
Locations
Internships and apprenticeships
People are a priority at Adamed, and their passion and dedication has helped us grow into a successful company. Recognising the value of our staff, we are committed to providing excellent work conditions and career opportunities.
Contact

Global English

Popular searches Innovations About Adamed Business Development Adamed worldwide Researches

x

Prizes and awards

12 October 2021

Prof. dr hab. Marcin Kołaczkowski, the Lead Scientist at Adamed Pharma and Vice-Dean for Development and Science of the Faculty of Pharmacy at the Jagiellonian University Medical College was the first laureate of Roman Kaliszan Prize awarded by the Medical University of Gdańsk, the Polpharma Scientific Foundation and the Scientific Society of Gdańsk. The prize was presented on 11^th October 2021 during the inauguration of the academic year at the Medical University of Gdańsk. The award was granted for the development of a new generation of GPCR receptor modulators in the search for therapies for psychiatric and neurodegenerative diseases.

Since 2007, prof. Marcin Kołaczkowski has been associated with Adamed Pharma. As the Lead Scientist in the Department of Innovation, he is involved in projects in the area of the central nervous system. He is also a scholarship holder of the Foundation for Polish Science and the winner of the scientific award of the Minister of Health. What is more, he was awarded the Golden Cross of Merit for his contribution to cooperation between science and industry. His scientific achievements include 8 patents and over 90 publications.

It is a great honor for me that the scientific community has recognized that it is me who should receive the first Roman Kaliszan Prize. It is even more special for me because the award is related to a legendary figure who brought so much to the world of science. - said prof. Kołaczkowski.